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For the three complex crystal structures of HIV-1 aspartic protease (an enzyme
of AIDS) with its inhibitor in the Protein Data Bank, molecular dynamics of the
generalized Born surface area and the ab initio fragment molecular orbital of an
ABINIT-MP calculation was performed to obtain the binding free energy, the
molecular orbital energy, the interaction energy of residueswith an inhibitor and
the charge transfer at the active site. The inhibitors are ﬁve symmetric cyclic
ureas, of which three were modelled, and an asymmetric dipeptide. The
interaction energy of the inhibitor at the active sites of aspartic acid is as great as
50 kcal mol
 1, coinciding with a tetrahedral transition state. For the inhibitor
with a higher afﬁnity, charge was transferred to the inhibitor from the active site.
The difference in symmetry of the inhibitor was not evident. Binding free energy
corresponds to the experimental value of the binding constant, while molecular
orbital energy does not always, which is considered to be an entropy effect.
Keywords: AIDS; aspartic protease inhibitor; molecular dynamics mm_gbsa; fragment
molecular orbital ABINIT-MP; tetrahedral transition states; active sites; interaction energy;
charge transfer.
1. Introduction
A retrovirus, human immunodeﬁciency virus (HIV), is the etiology of
acquired immunodeﬁciency syndrome (AIDS). HIV proliferates
under its own protease. HIV-1 PR is an important target enzyme for
the inhibition of HIV proliferation. HIV-1 PR consists of two chains,
which constitute a twofold rotational C2-symmetric homo-dimer.
Each chain consists of 99 amino acid residues and has the char-
acteristic disposition Asp–Thr–Gly of aspartic protease at positions
25–27. Fig. 1 shows the structure of HIV-1 PR complexed with a cyclic
urea inhibitor XK2 [Protein Data Bank (PDB) ID 1hvr; Lam et al.,
1994] viewed perpendicular to the C2 axis. The aspartic acid of the
active site hydrolyzes the peptide bond of the substrate catalytically
via a tetrahedral transition state (Doi et al., 2004). To analyze the
enzymatic reactions, the binding free energy of an inhibitor to the
enzyme is given by the equation G ¼  RT lnKi from the measured
binding constant Ki, where R is the gas constant and T is the absolute
temperature. It is also calculated by molecular dynamics taking the
water effect into account to compare with the experimental value
(Gohlke & Case, 2004). To ﬁnd the charge transfer between the
enzyme and an inhibitor, which seems important in enzymatic reac-
tions, quantum mechanics has to be applied after structural optimi-
zation by classical mechanics. It takes a tremendous amount of time
to complete quantum mechanical calculations of macromolecules
such as proteins. Here, a new method of quantum mechanics for
proteins, the fragment molecular orbital method (FMO) ‘ABINIT-
MP’, developed by one of the authors (Kitaura, Sawai et al., 1999;
Kitaura, Ikeo et al., 1999; Nakano et al., 2000, 2002), is used for both
binding energy and charge calculation.
2. Structural data
Two types of HIV-1 PR complex sample were selected: a complex
with a symmetric inhibitor corresponding to the C2-symmetric homo-
Figure 1
Structure of HIV-1 PR complexed with a cyclic urea inhibitor XK2 (Accelrys,
2001). Light-blue residues are less hydrophobic, red slightly hydrophobic, and
white Gly and others.
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ku, Tokyo, 152-0034, Japan.dimer of the PR, and a complex with an asymmetric inhibitor. Cyclic
urea was selected as the symmetric inhibitor and peptide derivative as
the asymmetric inhibitor. Of the X-ray diffraction structural data
deposited in the PDB, two complexes with cyclic urea (1hvr and 1ajx;
Hulte ´n et al., 1997; denoted AH1) and one with a peptide derivative
(1d4h; Andersson et al., 2003; denoted BEH) were selected. From
1hvr, three analogues were modelled: XK1, XK3 and XK4. The
structural formulae of all six inhibitors, crystals and modelled, are
shown in Fig. 2.
3. Calculation
3.1. Molecular dynamics, ‘mm_gbsa’
Molecular dynamics calculations were performed using AMBER
(Case et al., 2002), using the force ﬁeld gaff ‘general Amber force
ﬁeld’ and the generalized Born surface area model, mm_gbsa
(Srinivasan et al., 1998), of type 2, which takes a much shorter time
than the model that arranges water explicitly. Charges were given to
an inhibitor by RESP (restrained electrostatic potential) using
Antechamber, ‘an accessory software package for molecular
mechanical calculations’. The electrostatic potential input for RESP
was obtained by the quantum mechanical program GAUSSIAN
(Frisch et al., 1998) at the HF/6-31G* level. For molecular dynamics,
Sander (simulated annealing with NMR-derived
energy restraints) was run for 50 ps at 300 K,
during which time ten snapshots were sampled.
For two complex crystals, 1ajx and 1d4h, Sander
was minimized only and equilibrated over 5000
steps.
From the snapshots of the complex obtained
above, receptors and ligands were extracted to
obtain the free energy of the receptor, Greceptor,
and that of the ligand, Gligand. Binding free energy
G was calculated by the equation below,
G ¼ Gcomplex  ð Greceptor þ GligandÞ: ð1Þ
The electrostatic contribution to solvation free energy is calculated
by generalized Born (GB) methods. The hydrophobic contribution to
the solvation free energy is determined with a term dependent on the
solvent-accessible surface area (Sitkoff et al., 1994). The surface area
is computed using the MOLSURF program, which is based on an idea
primarily developed by Connolly (1983). The calculated G was
compared with the experimental value Gexp obtained from the
experimental binding constant ki,
Gexp ¼  RT lnKi; Ki ¼ 1=ki: ð2Þ
3.2. Fragment molcular orbital, ‘ABINIT-MP’
Molecular orbital calculations were performed via the fragment
molecular orbital method, using the message passing interface (MPI),
parallel version ‘ABINIT-MP’. In this method a protein is divided
into fragments by residues, at the default two residues per unit, as
shown in Fig. 3. Treating each N fragments as a monomer, two
fragments further are paired to form N(N   1)/2 dimers. The total
system is constituted of monomers and dimers. It is not necessary to
treat all the system at once, and parallel runs are possible to speed
up the calculation with only a small energy error. The interaction
between fragments in enzymes can be analyzed. The complex,
receptor and inhibitor obtained from the last snapshot of molecular
dynamics were locally minimized and used for input of the ABINIT-
MP molecular orbital to obtain the binding energy E. The basis set
used was 6-31G. Interactions between the inhibitor and the protease
receptor were obtained from the checkpoint ﬁle of the output.
4. Results and discussion
4.1. Binding free energy and fragment molecular orbital energy
G of the complexes with cyclic urea inhibitors [a complex crystal
with XK2 (1hvr) and three modelled complexes, XK1, XK3 and XK4]
obtained by molecular dynamics and E obtained by ABINIT-MP
are shown in Table 1(a). The G values of the XK series correspond
fairly well to the experimental value  RT lnKi, while the E values
do not correspond so well. The results for another complex crystal
with a cyclic urea, 1ajx, and an asymmetric dipeptide 1d4h inhibitor,
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Figure 2
Structural formulae of selected inhibitors to HIV-1 PR.
Figure 3
Dividing a protein into fragments, two residues per unit.
Figure 4
Substrate tetrahedral transition state of HIV-1 PR with negative charge.which have the largest and smallest binding constant, respectively, are
given in Table 1(b). G corresponds to the experimental value, while
E is reversed. Ereceptor of both crystals has almost the same value
77491.0 a.u. The difference between G and E is considered to be
entropy and solvent effect (Raha & Merz, 2004). E seems to
correspond to the quantum mechanical part of Hf.
G ¼ G
g
b þ G
receptor ligand
solv  ð G
receptor
solv þ G
ligand
solv Þ; ð3Þ
G
g
b ¼ H
g
b   TS
g
b; ð4Þ
H
g
b ¼ Hf þð 1=R
6ÞLJ; ð5Þ
Sg ¼ SAC;N;O;S þ numðrotbondsÞ; ð6Þ
where H and S are the enthalpy and entropy change, respectively,
LJ is the Lenard–Jones potential, SAC,N,O,S is the solvent entropy
based on the surface area burial C, N, O and S atoms, num(rot bonds)
is the number of rotational bods in the ligands, and sub- and super-
scripts b, solv, f and g denote binding, solvation, heat of formation and
gas phase, respectively. The dispersive part of nonpolar interaction
ð1=R6ÞLJ is calculated using the attractive part of the Lennard–Jones
potential. It has been found by isothermal titration calorimetry of the
binding that an inhibitor with high afﬁnity is strongly exothermic
(favorable enthalpy change,  7.6 kcal mol
 1) and has a more
balanced distribution of enthalpic and entropic interactions (Velaz-
quez-Campoy et al., 2001). The entropic term should be calculated by
normal mode analysis in molecular dynamics.
4.2. Interaction of inhibitors with HIV-1 protease residues
As stated in the Introduction, in HIV-1 PR, Asp25 and Asp124 at
the active sites hydrolyze a peptide bond of the substrate catalytically
via not a triangular but a tetrahedral transition state bearing a
negative charge like other PRs (Ser PR for example; Branden &
Tooz, 1999), as shown in Fig. 4 (Doi et al., 2004). ABINIT-MP is able
to calculate not only the total binding energy but also the interaction
diffraction structural biology
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Figure 5
Interacton of HIV-1 PR residues and inhibitors XK1–BEH. Energy in kcal mol
 1;
numbering of residues is through the dimer; each has 99 residues.
Table 2
Charge transfer from receptor to inhibitor, q, at the active site (in a.u.).
Active site Ligand qcomplex qreceptor q
Asp25 AH1  0.7354  0.7558 0.0204
BEH  0.7445  0.8009 0.0564
Asp124 AH1  0.77786  0.77473  0.0031
BEH  0.82909  0.81347  0.0156
Table 1
Binding free energy G and fragment molecular orbital energy E (kcal mol
 1)o f
HIV-1 PR with its inhibitor compared with experimental values: (a) a complex
crystal with cyclic urea (XK2) and three (XK1, XK3, XK4) modelled from XK2
(1hvr); (b) two complex crystals with cyclic urea (AH1; 1ajx) and a dipeptide BEH
(1d4h).
Inhibitor Ki (nM)  RT lnKi G E
(a)
XK1 4.7  11.43  32.37  39.34
XK2 0.31  13.05  57.03  39.85
XK3 2.14  11.94  37.28  36.96
XK4 0.27  13.13  46.56  49.51
(b)
AH1 12.2  10.86  46.22  70.01
BEH 0.10  13.73  54.38  47.00between residues of the receptor and the inhibitor, and the charge
transfer from the receptor to the inhibitor at the active site,
q ¼ qcomplex   qreceptor, where the complex consists of a receptor and
an inhibitor (Nakano & Kato, 2004). The electric charge was calcu-
lated using Mulliken’s method. The interaction energies of the inhi-
bitors and the protease are shown in Fig. 5. The interactions at the
active sites, Asp25 and Asp124, are as great as 50 kcal mol
 1,
corresponding to the tetrahedral transition state. The interactions are
not necessarily balanced at both sites in symmetrical cyclic urea
inhibitors (XK series and AH1), but conversely the lower the binding
constant, the more balanced the interaction. Hydrogen bonds are
formed between the inhibitors, AH1 and BEH, and the active sites,
Asp25 and Asp124, as shown in Fig. 6, corresponding to the transition
state. In the symmetric cyclic urea inhibitor AH1, the two hydrogen-
bond lengths between the hydroxy group of AH1 and sites Asp25 and
Asp124 are almost equal (1.961 and 1.870 A ˚ , respectively), while in
the asymmetric dipeptide BEH, the length difference is greater (1.928
and 2.559 A ˚ ). The charge transferred from the receptor to the inhi-
bitor, q, at the active sites of the two complex crystals is shown in
Table 2. At the active site Asp25, the charge transfer from receptor to
inhibitor of high-afﬁnity BEH is larger than that of low-afﬁnity AH1,
while at the other site, Asp124, the direction of the charge transfer is
reversed and the value is low.
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Figure 6
Hydrogen bonds between inhibitor and active sites. PR protein is drawn in C ,
inhibitor, active sites Asp25 and Asp124 in wire frame. C atoms are colored green,
O atoms red, N atoms blue and H atoms white. The inhibitor is (a) a cyclic urea
(AH1) and (b) a dipeptide (BEH).